Cancer BiologybioRxiv
Serum Flt3 ligand is a biomarker of progenitor cell mass and prognosis in acute myeloid leukemia
P. Milne, C. Wilhelm-Benartzi, M. R. Grunwald…·M. Collin
This paper shows that serum Flt3L levels correlate with progenitor cell mass and prognosis in AML, with lower levels linked to worse outcomes and relapse.
DOI 10.1182/bloodadvances.2019000197